VanEck Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,878
| Closed | -$810K | – | 1435 |
|
|
2023
Q2 | $810K | Sell |
7,878
-817
| -9% | -$84K | ﹤0.01% | 915 |
|
|
2023
Q1 | $949K | Sell |
8,695
-6,767
| -44% | -$739K | ﹤0.01% | 846 |
|
|
2022
Q4 | $1.76M | Sell |
15,462
-442
| -3% | -$50.3K | ﹤0.01% | 699 |
|
|
2022
Q3 | $984K | Buy |
15,904
+4,636
| +41% | +$287K | ﹤0.01% | 775 |
|
|
2022
Q2 | $899K | Sell |
11,268
-1,252
| -10% | -$99.9K | ﹤0.01% | 810 |
|
|
2022
Q1 | $1.32M | Buy |
12,520
+1,308
| +12% | +$138K | ﹤0.01% | 786 |
|
|
2021
Q4 | $1.21M | Buy |
11,212
+1,749
| +18% | +$188K | ﹤0.01% | 813 |
|
|
2021
Q3 | $1.04M | Buy |
9,463
+2,029
| +27% | +$222K | ﹤0.01% | 802 |
|
|
2021
Q2 | $696K | Buy |
7,434
+295
| +4% | +$27.6K | ﹤0.01% | 862 |
|
|
2021
Q1 | $657K | Buy |
+7,139
| New | +$657K | ﹤0.01% | 810 |
|